The annual WANECAM 2 congress, combined with a Project Management Board meeting, took place on December 4-5, 2024, at the Hôtel Boulevard in Libreville, Gabon. The event was attended by Prof. Abdoulaye Djimdé, coordinator of the consortium, Dr. Rella Manego, principal investigator for the Gabonese site, and Prof. Ghyslain Mombongoma. Highlights of the Meeting Outlook…
From October 28 to 31, 2024, an enriching training on writing scientific articles was held in a hybrid format at the DELGEME Plus training center in Point G. This initiative brought together 60 participants, all eager to enhance their scientific writing skills and tackle the challenges associated with scientific publication. A Training Focused on Participants’…
On Thursday, April 25, 2024, WANECAM 2 in partnership with the National Malaria Control Program celebrated World Malaria Day under the theme: Promoting health equity, gender equality and human rights. Highlighting the disproportionate effect of the malaria endemic on women and girls, as care providers and patients affected by the disease. The event took place at the…
New Orleans, 15 November 2024 – The West African Network for Clinical Trials of Antimalarial Drugs (WANECAM2) consortium is pleased to announce positive results from the Phase 2b KALUMI study of the novel, non-artemisinin drug ganaplacide combined with a new once-daily formulation of lumefantrine. KALUMI is a Phase 2 randomized, open-label, non-inferiority study evaluating the…
Context The involvement of young girls at all stages of their lives in Science is a major focus of the WANECAM 2 project, which encourages young girls to study Science in order to promote the female gender. Hence, WANECAM 2 in partnership with the Amazons of the Faculty of Medicine and Odonto-stomatology (FMOS) and the…
Context As part of its capacity building activities, the WANECAM 2 project has initiated a pedagogical workshop for MRTC-Parasito PhDs for the review of theses with the aim of better formalizing the follow-up of all PhDs to enhance the quality of human resources that MRTC-Parasito trains locally. Objective This activity took place from 19 to…
Novartis and Medicines for Malaria Venture announce decision to move to Phase 3 study for novel ganaplacide/lumefantrine-SDF combination in adults and children with malaria Basel, November 23, 2022 — As the threat of resistance to current malaria treatments grows1,2, Novartis and MMV announce the decision to progress ganaplacide/lumefantrine- solid dispersion formulation (SDF) into Phase 3 development for the treatment…
Context : Most African countries do not conduct research in structural biology due to limited resources, lack of trained people and brain drain of qualified scientists. Thus WANECAM 2 and BIO-STRUCT organised a training workshop in Structural Biology in the Bioinformatics Room of DELGEME in Bamako, Mali from 25 to 28 April 2022. The opening…
Context As part of its capacity building activities, WANECAM 2 initiated a workshop for its PhDs students and extended to all MRTC-Parasito PhDs to review their thesis work. This in order to better formalize their supervision and enhance the quality of human resources trained locally at MRTC-Parasito. Objectives This activity took place from 19 to…
Malaria is frequently mentioned in symposia, seminars and meetings, is at the centre of our concerns and the international community remains mobilized to combat this disease through research and other initiatives. Still, every minute a child under the age of five dies of malaria in the world. In the face of this reality, challenges to…
